Amicus opens UCity R&D tower, calls Philly the ‘Cradle of Cures’

The future of research and development, in rare diseases and beyond, is Philadelphia.

By moving its R&D team to University City this year, publically traded gene therapy company Amicus Therapeutics now calls the Greater Philadelphia region’s bustling cell and gene therapy ecosystem home.

Article from the Philadelphia Inquirer